January 2009 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Rapidly Changing Moles Associated with 'Sun Tan Jab'
WEDNESDAY, Jan. 28 (HealthDay News) -- An untested, injectable drug that is sold on the Internet for its tanning properties is associated with rapidly changing moles, according to an article published online Jan. 27 in BMJ.
Clinical Information Technology Leads to Safer Hospitals
TUESDAY, Jan. 27 (HealthDay News) -- Hospitals that make use of clinical information technology to automate notes, records, order entry and clinical decision support have lower mortality rates, fewer complications and also save money, according to a report published in the Jan. 26 issue of the Archives of Internal Medicine.
Novel Light Imaging Technique Detects Melanoma
WEDNESDAY, Jan. 21 (HealthDay News) -- Multimodal polarized light imaging using tetracycline or methylene blue is an effective strategy to image dysplastic and benign nevi in melanoma, researchers report in the January issue of Lasers in Surgery and Medicine.
Psoriasis Support Sites Linked to Perceived Improvements
TUESDAY, Jan. 20 (HealthDay News) -- Virtual communities of psoriasis patients allow users to benefit from educational resources as well as psychological and social support systems, researchers report in the January issue of the Archives of Dermatology.
Increased Mortality Linked to Topical Retinoid Usage
MONDAY, Jan. 19 (HealthDay News) -- Topical tretinoin, a frequently prescribed retinoid cream, is associated with increased all-cause mortality, according to study results published in the January issue of the Archives of Dermatology.
Engineered Skin Improves Healing of Burn Wounds
MONDAY, Jan. 19 (HealthDay News) -- Tissue-engineered skin made from stem cells improves wound healing in a pig burn model, according to a study published online Dec. 22 in Artificial Organs.
Survival Similar for Interferon Regimens for Melanoma
WEDNESDAY, Jan. 14 (HealthDay News) -- Four weeks of intense immunotherapy with interferon-alfa (IFN-α) or a year of lower-dose maintenance treatment with IFN-α produce similar survival in patients with high-risk melanoma, according to a report published online Jan. 12 in the Journal of Clinical Oncology.
Melanoma an Increasing Burden in United States
MONDAY, Jan. 12 (HealthDay News) -- Improved access to screening for malignant melanoma does not explain the increased incidence of the disease in the United States, according to a study published online Jan. 8 in the Journal of Investigative Dermatology.